Michael Völk

1.6k total citations
29 papers, 954 citations indexed

About

Michael Völk is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Michael Völk has authored 29 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 13 papers in Hepatology and 7 papers in Epidemiology. Recurrent topics in Michael Völk's work include Organ Transplantation Techniques and Outcomes (13 papers), Liver Disease and Transplantation (11 papers) and Organ Donation and Transplantation (6 papers). Michael Völk is often cited by papers focused on Organ Transplantation Techniques and Outcomes (13 papers), Liver Disease and Transplantation (11 papers) and Organ Donation and Transplantation (6 papers). Michael Völk collaborates with scholars based in United States, Türkiye and Italy. Michael Völk's co-authors include Anna S. Lok, Jorge A. Marrero, Sameer D. Saini, Sandeep Vijan, Rachel Tocco, Michael J. Englesbe, Peter A. Ubel, Christopher J. Sonnenday, David A. Bush and Jason C. Smith and has published in prestigious journals such as Gastroenterology, Hepatology and Cancer.

In The Last Decade

Michael Völk

29 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Völk United States 15 676 447 401 157 128 29 954
Alan Wigg Australia 16 782 1.2× 377 0.8× 594 1.5× 49 0.3× 47 0.4× 79 1.0k
Esteban Cugat Spain 13 462 0.7× 583 1.3× 127 0.3× 90 0.6× 78 0.6× 35 747
Hwan Y. Yoo United States 15 818 1.2× 584 1.3× 579 1.4× 50 0.3× 145 1.1× 23 1.0k
Matthew Bowles United Kingdom 14 520 0.8× 555 1.2× 205 0.5× 116 0.7× 119 0.9× 33 827
Murat Dayangaç Türkiye 17 515 0.8× 561 1.3× 190 0.5× 366 2.3× 37 0.3× 73 921
Mikel Gastaca Spain 16 604 0.9× 637 1.4× 214 0.5× 152 1.0× 222 1.7× 46 860
Evaristo Varó Spain 15 525 0.8× 590 1.3× 268 0.7× 110 0.7× 380 3.0× 59 1.0k
Samantha M. Noreen United States 10 554 0.8× 625 1.4× 278 0.7× 219 1.4× 290 2.3× 18 957
Félix Alegre Spain 12 357 0.5× 208 0.5× 251 0.6× 22 0.1× 29 0.2× 24 549
Yuval A. Patel United States 15 322 0.5× 313 0.7× 300 0.7× 84 0.5× 55 0.4× 50 740

Countries citing papers authored by Michael Völk

Since Specialization
Citations

This map shows the geographic impact of Michael Völk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Völk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Völk more than expected).

Fields of papers citing papers by Michael Völk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Völk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Völk. The network helps show where Michael Völk may publish in the future.

Co-authorship network of co-authors of Michael Völk

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Völk. A scholar is included among the top collaborators of Michael Völk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Völk. Michael Völk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bush, David A., Michael Völk, Jason C. Smith, et al.. (2023). Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial. Cancer. 129(22). 3554–3563. 23 indexed citations
2.
Uckun, Fatih M., Muhammad Saeed, İbrahim H. Özercan, et al.. (2022). Evaluation of the Potential Of Rejuveinix Plus Dexamethasone Against Sepsis. Future Microbiology. 17(15). 1217–1229. 1 indexed citations
3.
Uckun, Fatih M., et al.. (2021). Non-clinical safety profile and pharmacodynamics of two formulations of the anti-sepsis drug candidate Rejuveinix (RJX). Biomedicine & Pharmacotherapy. 141. 111823–111823. 3 indexed citations
4.
5.
Hsu, Evelyn, Michele L. Shaffer, Lucy L. Gao, et al.. (2017). Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List. Gastroenterology. 153(4). 988–995. 46 indexed citations
6.
Bush, David A., Jason C. Smith, Jerry D. Slater, et al.. (2016). Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis. International Journal of Radiation Oncology*Biology*Physics. 95(1). 477–482. 90 indexed citations
7.
Vaughn, Valerie M., David C. Cron, Michael N. Terjimanian, et al.. (2015). Analytic morphomics identifies predictors of new‐onset diabetes after liver transplantation. Clinical Transplantation. 29(5). 458–464. 11 indexed citations
8.
Völk, Michael, et al.. (2014). Pilot test of a patient decision aid about liver transplant organ quality. Liver Transplantation. 20(7). 850–855. 17 indexed citations
9.
Völk, Michael, et al.. (2013). Systematic bias in surgeons' predictions of the donor-specific risk of liver transplant graft failure. Liver Transplantation. 19(9). 987–990. 19 indexed citations
10.
Völk, Michael, et al.. (2011). Variation in Organ Quality between Liver Transplant Centers. American Journal of Transplantation. 11(5). 958–964. 40 indexed citations
11.
Vitale, Alessandro, Michael Völk, Martina Gambato, et al.. (2010). Estimation of the Harm to the Waiting List as a Crucial Factor in the Selection of Patients With Hepatocellular Carcinoma for Liver Transplantation. Transplantation Proceedings. 42(4). 1194–1196. 13 indexed citations
12.
Cillo, Umberto, Alessandro Vitale, Michael Völk, et al.. (2010). The survival benefit of liver transplantation in hepatocellular carcinoma patients. Digestive and Liver Disease. 42(9). 642–649. 37 indexed citations
13.
Völk, Michael, et al.. (2009). Geographic Variation in Organ Availability Is Responsible for Disparities in Liver Transplantation between Hispanics and Caucasians. American Journal of Transplantation. 9(9). 2113–2118. 40 indexed citations
14.
Völk, Michael, Rachel Tocco, Sameer D. Saini, & Anna S. Lok. (2009). Public health impact of antiviral therapy for hepatitis C in the United States†. Hepatology. 50(6). 1750–1755. 184 indexed citations
15.
Englesbe, Michael J., et al.. (2009). Centers for Disease Control ‘High-Risk’ Donors and Kidney Utilization. American Journal of Transplantation. 10(2). 416–420. 70 indexed citations
16.
Völk, Michael, Sandeep Vijan, & Jorge A. Marrero. (2008). A Novel Model Measuring the Harm of Transplanting Hepatocellular Carcinoma Exceeding Milan Criteria. American Journal of Transplantation. 8(4). 839–846. 140 indexed citations
17.
Völk, Michael, Anna S. Lok, Shawn J. Pelletier, Peter A. Ubel, & Rodney A. Hayward. (2008). Impact of the Model for End-Stage Liver Disease Allocation Policy on the Use of High-Risk Organs for Liver Transplantation. Gastroenterology. 135(5). 1568–1574. 41 indexed citations
18.
19.
Luedtke, Robert R., Cathy L. Bell-Horner, Michael Völk, Manfred G. Reinecke, & Glenn H. Dillon. (2004). Pharmacological Survey of Medicinal Plants for Activity at Ligand-Gated Ion Channels: Selective Interaction with 5-HT3 Receptors. Pharmaceutical Biology. 42(1). 73–82. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan Wigg Breakdown of academic impact, for papers by Esteban Cugat Breakdown of academic impact, for papers by Hwan Y. Yoo Breakdown of academic impact, for papers by Matthew Bowles Breakdown of academic impact, for papers by Murat Dayangaç Breakdown of academic impact, for papers by Mikel Gastaca Breakdown of academic impact, for papers by Evaristo Varó Breakdown of academic impact, for papers by Samantha M. Noreen Breakdown of academic impact, for papers by Félix Alegre Breakdown of academic impact, for papers by Yuval A. Patel
Rankless by CCL
2026